Diabetic Macular Edema Clinical Trials

1. A Phase 2, Randomized, Double Masked, Placebo Controlled, Dose Ranging Clinical Study to Assess the Safety and Efficacy of Subconjunctival Injections of Sirolimus in Patients with Diabetic Macular Edema Secondary to Diabetic Retinopathy